Mr Mads Oerbaek Andersen

Copenhagen University Hospital, Copenhagen (Denmark)

Follow

Contributor content

Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension

Presentation

Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension

Risk stratification parameters as assessed by continuous long-term cardiac monitoring in pulmonary hypertension - heart rate variability, heart rate, and physical activity

Presentation

Risk stratification parameters as assessed by continuous long-term cardiac monitoring in pulmonary hypertension - heart rate variability, heart rate, and physical activity

Heart rate variability in patients with pulmonary hypertension as assessed with long-term continuous cardiac monitoring correlates with other established risk assessment parameters

Presentation

Heart rate variability in patients with pulmonary hypertension as assessed with long-term continuous cardiac monitoring correlates with other established risk assessment parameters

Arrhythmias assessed with long-term continuous cardiac monitoring in pulmonary hypertension

Presentation

Arrhythmias assessed with long-term continuous cardiac monitoring in pulmonary hypertension

Arrhythmias and heart rate variability before and after lung transplantation assessed by continuous cardiac monitoring in a patient with end-stage pulmonary arterial hypertension.

Presentation

Arrhythmias and heart rate variability before and after lung transplantation assessed by continuous cardiac monitoring in a patient with end-stage pulmonary arterial hypertension.

ESC 365 is supported by

novartis

Explore sponsored resources